CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in CalciMedica, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +8 vs. Q4 2023
- Shares held
- 3.55M
- +3.03M (+585.0%) vs. Q4 2023
- Total value
- $14.8M
- +$13.3M (+894.1%) vs. Q4 2023
- New holders
- 9
- 6 more added
- Sold out
- 1
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CALC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $8.39M |
| Q1 2026 | 27 | $592.5K |
| Q4 2025 | 31 | $24.2M |
| Q3 2025 | 31 | $10.9M |
| Q2 2025 | 30 | $5.93M |
| Q1 2025 | 30 | $7.49M |
| Q4 2024 | 29 | $15.1M |
| Q3 2024 | 24 | $13.6M |
| Q2 2024 | 21 | $11.8M |
| Q1 2024 | 20 | $14.8M |
| Q4 2023 | 12 | $1.49M |
| Q3 2023 | 13 | $1.56M |
| Q2 2023 | 13 | $2.72M |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 27 | $5.97M |
| Q3 2022 | 25 | $10.2M |
| Q2 2022 | 25 | $11.7M |
| Q1 2022 | 27 | $13.5M |
| Q4 2021 | 28 | $20.7M |
| Q3 2021 | 27 | $37.0M |
| Q2 2021 | 41 | $63.7M |
| Q1 2021 | 51 | $72.8M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding CalciMedica, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 1,000,000 | $4.16M | 0.07% | +1,000,000 | New |
| Soleus Capital Management, L.P. | 783,904 | $3.26M | 0.29% | +783,904 | New |
| Stonepine Capital Management, LLC | 522,602 | $2.17M | 1.72% | +522,602 | New |
| Aisling Capital Management LP | 521,114 | $2.17M | 0.73% | +521,114 | New |
| OrbiMed Advisors LLC | 297,380 | $1.24M | 0.02% | 00.0% | Unchanged |
| BML Capital Management, LLC | 160,424 | $667.4K | 0.45% | +15,000+10.3% | Added |
| Alyeska Investment Group, L.P. | 75,082 | $312.3K | 0.00% | +75,082 | New |
| Millennium Management LLC | 66,134 | $275.1K | 0.00% | +66,134 | New |
| Meritage Portfolio Management | 46,000 | $191.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 44,686 | $185.9K | 0.00% | +31,332+234.6% | Added |
| Vanguard Group Inc | 13,359 | $55.6K | 0.00% | +13,359 | New |
| First Manhattan Co | 13,226 | $55.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,181 | $10.9K | 0.00% | +764+53.9% | Added |
| Qube Research & Technologies Ltd | 1,229 | $5.11K | 0.00% | +1,228+122,800.0% | Added |
| Morgan Stanley | 856 | $3.56K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 781 | $3.25K | 0.00% | +781 | New |
| Bank of America Corp | 507 | $2.11K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 55 | $229 | 0.00% | +39+243.8% | Added |
| UBS Group AG | 16 | $66 | 0.00% | +2+14.3% | Added |
| JPMorgan Chase & Co | 14 | $58 | 0.00% | +14 | New |
| Cutler Group LP | 0 | $0 | 0.00% | −14−100.0% | Sold out |